Related Experiment Videos
Visual-evoked potentials in the assessment of optic gliomas
1Department of Neurology, Royal Alexandra Hospital for Children, Westmead, NSW, Australia.
Insights
Visual-evoked potentials (VEPs) show high sensitivity for detecting optic pathway gliomas in children with neurofibromatosis type 1. VEPs also aid in monitoring glioma progression, offering a valuable tool for this high-risk group.
Area of Science:
- Ophthalmology
- Pediatric Neurology
- Neuro-oncology
Background:
- Optic pathway gliomas (OPGs) are a significant concern in children with neurofibromatosis type 1 (NF1).
- Children under 6 years old are most susceptible to OPG development.
- Current screening methods like annual ophthalmologic exams are often unreliable in young children, while MRI is sensitive but costly and requires anesthesia.
Purpose of the Study:
- To evaluate the sensitivity of visual-evoked potentials (VEPs) in detecting OPGs in children with NF1.
- To determine the utility of VEPs in monitoring the progression of OPGs.
- To establish VEPs as a potential screening or monitoring aid for OPGs in this pediatric population.
Main Methods:
- Retrospective analysis of VEP data in children with NF1.
- Comparison of VEP results with confirmed OPG diagnoses.
- Assessment of VEP changes over time in patients with diagnosed OPGs.
Main Results:
- VEPs demonstrated significant sensitivity in detecting the presence of OPGs.
- VEPs provided valuable information regarding the progression of OPGs.
- The findings support VEPs as a sensitive diagnostic and monitoring tool for OPGs in NF1 patients.
Conclusions:
- VEPs are a sensitive method for detecting optic pathway gliomas in children with neurofibromatosis type 1.
- VEPs can effectively monitor the progression of optic pathway gliomas.
- VEPs represent a promising alternative or adjunct to current screening and monitoring methods for OPGs in this vulnerable pediatric group.
Abstract:
The most effective method for the screening and monitoring of optic pathway gliomas in children with neurofibromatosis type 1 remains a dilemma. Children less than 6 years of age are the group at highest risk for the development of optic pathway gliomas. Although an annual ophthalmologic examination currently is recommended as the most efficient method to screen for optic pathway gliomas, this method is often unreliable and inaccurate in young children. Magnetic resonance imaging remains the most sensitive test; however, cost and the need for sedation or general anaesthetic preclude its use as a routine screening test. We previously have recommended visual-evoked potentials (VEPs) as a possible alternative or aid in the assessment of optic pathway gliomas in this group of patients. The aims of this study were to ascertain the sensitivity of VEPs in detecting optic pathway gliomas and to determine whether VEPs are useful in monitoring the progress of optic pathway gliomas. This study provides further evidence of the sensitivity of VEPs in detecting optic pathway gliomas. In addition, VEPs may provide additional useful information concerning the progression of optic pathway gliomas once they have been detected.